SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-008094
Filing Date
2019-03-18
Accepted
2019-03-15 19:04:29
Documents
8
Period of Report
2019-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bioc-8k_20190315.htm 8-K 52073
2 EX-4.1 bioc-ex41_10.htm EX-4.1 143333
3 EX-5.1 bioc-ex51_8.htm EX-5.1 16012
4 EX-10.1 bioc-ex101_9.htm EX-10.1 271715
5 EX-10.2 bioc-ex102_7.htm EX-10.2 139248
6 EX-99.1 bioc-ex991_6.htm EX-99.1 12991
7 GRAPHIC gwbwfbiijd1g000001.jpg GRAPHIC 28720
8 GRAPHIC gamur4ujb51h000001.jpg GRAPHIC 7292
  Complete submission text file 0001564590-19-008094.txt   686443
Mailing Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 330757995 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36284 | Film No.: 19686391
SIC: 8071 Services-Medical Laboratories